Establishment Labs Navigates Q1 2026 Momentum, Ramps Revenue Forecast and Cash Position

Establishment Labs Holdings Inc. reported a solid top-line step-up for the quarter ended March 31, 2026. Revenue reached $59.9 million, up 44.7% from the year-ago period (vs. $41.4 million in Q1 2025). A notable driver: Motiva U.S. sales rose to $19.6 million, up from $6.2 million in the prior year, underscoring the U.S. launch as a meaningful contributor to growth.

The company highlighted a gross margin of 70.7% for the quarter, a positive step relative to 67.2% in the year-ago period. On the profitability line, management disclosed a loss from operations of $6.5 million, but also reported Adjusted EBITDA income of $1.2 million, signaling improving operating leverage even as the business continues to invest in growth. Cash and liquidity remained a talking point, with a cash balance of $68.1 million as of March 31, 2026.

Where the growth lives

The quarter’s momentum appears to be broadening beyond its traditional markets. The U.S. Motiva contribution points to a budding shift in portfolio mix, while the statement that momentum is accelerating across both the United States and outside the U.S. markets hints at a multi-regional lift. The minimally invasive platform, which the company describes as a strategic growth vector, is positioned to become a more meaningful portion of 2026 revenue—management now guiding for a material contribution, up from prior expectations.

From a product and platform perspective, the emphasis on Motiva and the associated adoption is a recurring theme. The narrative suggests that revenue growth is not merely from price or volume in one market, but rather from a broader platform strategy that could translate into improved margin dynamics as the business scales.

Guidance and the capital story

Guidance data surfaced in the release shows a raised revenue forecast for 2026, with expectations now in the neighborhood of roughly $266.5 million to $268.5 million. The guidance upgrade signals confidence in the ongoing rollout and theearly-stage profitability that the company is beginning to demonstrate through Adjusted EBITDA maintenance, even amid investments into growth initiatives.

On the capital side, the company highlighted a refinancing with Oaktree that extends debt maturity and enhances financial flexibility. Management framed this as a structural improvement capable of supporting the dual goals of accelerating growth and returning a path toward positive free cash flow in the second half of the year.

Operational metrics, margins, and balance sheet health

• Revenue: $59.9 million for Q1 2026, up 44.7% year over year.
• Motiva U.S. revenue: $19.6 million, up from $6.2 million in the prior-year period.
• Gross margin: 70.7% for the quarter, versus 67.2% a year earlier.
• Operating income: Loss from operations of $6.5 million.
• Adjusted EBITDA: Positive $1.2 million for the quarter.
• Cash: $68.1 million as of March 31, 2026.

The quarterly narrative also notes that cash use in the period was modest relative to the year-ago quarter, aligning with a broader goal of turning operating momentum into meaningful cash flow in the second half of 2026. The mix shift toward Motiva, combined with margin expansion, suggests the potential for a more constructive earnings trajectory if growth investments scale as planned.

Outlook for ESTA and peers

From a sector lens, the emphasis on a diversified geographic footprint and a minimally invasive product suite could position ESTA among the more notable momentum stories in the aesthetic medical devices space. If the trajectory holds, investors will be watching for a couple of things: how the reported EPS evolves as the company matures its top line and cost structure, whether there is a visible earnings surprise or disappointing variance relative to consensus expectations, and how the revenue forecast shapes up as the year unfolds.

Crucially, the refinancing provides runway for the balance sheet to absorb continued investment in sales, marketing, and product development without immediate liquidity pressure. In a market where peers are balancing growth with profitability, ESTA’s path toward free cash flow positivity in H2 could become a differentiator, assuming the growth remains durable and the cost base stabilizes.

Notes and interpretation

Readers should note that the press-release language in the filing emphasizes momentum and guidance rather than a declared earnings surprise. The quarter’s actual GAAP EPS figure is not cited in the excerpt, and the market will rely on forthcoming quarterly results to gauge true per-share profitability against consensus estimates. The excerpt ends mid-sentence on the gross profit discussion, so the final quarterly detail could flesh out additional nuances about gross margin drivers and cost controls.

Overall, the report paints a picture of a company transitioning from early-stage expansion to a more sustainable growth phase, with a legitimate shot at turning cash generation into a tangible investor-friendly outcome in the back half of 2026. If the U.S. Motiva momentum translates into durable revenue and margin expansion, ESTA could emerge as a reference point for peers chasing a similar platform-driven growth arc.